BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 34479599)

  • 1. TLR4 signaling in the development of colitis-associated cancer and its possible interplay with microRNA-155.
    Guo J; Liao M; Wang J
    Cell Commun Signal; 2021 Sep; 19(1):90. PubMed ID: 34479599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TLR4 Signaling Impedes Tumor Growth in Colitis-Associated Colon Cancer.
    Pastille E; Faßnacht T; Adamczyk A; Ngo Thi Phuong N; Buer J; Westendorf AM
    Front Immunol; 2021; 12():669747. PubMed ID: 34025672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
    Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
    Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-6869-5p acts as a tumor suppressor via targeting TLR4/NF-κB signaling pathway in colorectal cancer.
    Yan S; Liu G; Jin C; Wang Z; Duan Q; Xu J; Xu D
    J Cell Physiol; 2018 Sep; 233(9):6660-6668. PubMed ID: 29206292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-29a-5p/STAT3 Positive Feedback Loop Regulates TETs in Colitis-Associated Colorectal Cancer.
    Wang A; Deng S; Chen X; Yu C; Du Q; Wu Y; Chen G; Hu L; Hu C; Li Y
    Inflamm Bowel Dis; 2020 Mar; 26(4):524-533. PubMed ID: 31750910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between
    Proença MA; Biselli JM; Succi M; Severino FE; Berardinelli GN; Caetano A; Reis RM; Hughes DJ; Silva AE
    World J Gastroenterol; 2018 Dec; 24(47):5351-5365. PubMed ID: 30598580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epithelial TLR4 Signaling Activates DUOX2 to Induce Microbiota-Driven Tumorigenesis.
    Burgueño JF; Fritsch J; González EE; Landau KS; Santander AM; Fernández I; Hazime H; Davies JM; Santaolalla R; Phillips MC; Diaz S; Dheer R; Brito N; Pignac-Kobinger J; Fernández E; Conner GE; Abreu MT
    Gastroenterology; 2021 Feb; 160(3):797-808.e6. PubMed ID: 33127391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis.
    Jin BR; Chung KS; Hwang S; Hwang SN; Rhee KJ; Lee M; An HJ
    Neoplasia; 2021 Jun; 23(6):561-573. PubMed ID: 34077834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pellino 3 promotes the colitis-associated colorectal cancer through suppression of IRF4-mediated negative regulation of TLR4 signalling.
    Kim YM; Kim HY; Ha Thi HT; Kim J; Lee YJ; Kim SJ; Hong S
    Mol Oncol; 2023 Nov; 17(11):2380-2395. PubMed ID: 37341064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bortezomib Sustains T Cell Function by Inducing miR-155-Mediated Downregulation of SOCS1 and SHIP1.
    Renrick AN; Thounaojam MC; de Aquino MTP; Chaudhuri E; Pandhare J; Dash C; Shanker A
    Front Immunol; 2021; 12():607044. PubMed ID: 33717088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Overexpression of miR-31 regulates TLR4/NF-κB signaling pathway and apoptotic protein in colitis model mice].
    Liu KL; DU XX; Zhang WQ; Wu YL; Wang X; Wang CF; Cui XL
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 May; 36(3):211-215. PubMed ID: 32981274
    [No Abstract]   [Full Text] [Related]  

  • 12. Innate immune signaling by Toll-like receptor-4 (TLR4) shapes the inflammatory microenvironment in colitis-associated tumors.
    Fukata M; Hernandez Y; Conduah D; Cohen J; Chen A; Breglio K; Goo T; Hsu D; Xu R; Abreu MT
    Inflamm Bowel Dis; 2009 Jul; 15(7):997-1006. PubMed ID: 19229991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine induces SOCS1 pathway to reprogram the M1 polarization of macrophages via miR-155-5p in colitis-associated colorectal cancer.
    Ling Q; Fang J; Zhai C; Huang W; Chen Y; Zhou T; Liu Y; Fang X
    Eur J Pharmacol; 2023 Jun; 949():175724. PubMed ID: 37059377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel evidence for an oncogenic role of microRNA-21 in colitis-associated colorectal cancer.
    Shi C; Yang Y; Xia Y; Okugawa Y; Yang J; Liang Y; Chen H; Zhang P; Wang F; Han H; Wu W; Gao R; Gasche C; Qin H; Ma Y; Goel A
    Gut; 2016 Sep; 65(9):1470-81. PubMed ID: 25994220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-198 regulated the tumorigenesis of gastric cancer by targeting Toll-like receptor 4 (TLR4).
    Quan XQ; Xie ZL; Ding Y; Feng R; Zhu XY; Zhang QX
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(8):2287-2296. PubMed ID: 29762851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of guluronic acid (G2013) on SHIP1, SOCS1 induction and related molecules in TLR4 signaling pathway.
    Mortazavi-Jahromi SS; Farazmand A; Motamed N; Navabi SS; Mirshafiey A
    Int Immunopharmacol; 2018 Feb; 55():323-329. PubMed ID: 29310108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p53 affects epigenetic signature on SOCS1 promoter in response to TLR4 inhibition.
    Sheikh T; Sen E
    Cytokine; 2021 Apr; 140():155418. PubMed ID: 33476981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of therapeutic mechanism of
    Zhang X; Chen Y; Li Z; Shang J; Yuan Z; Deng W; Luo Y; Han N; Yin P; Yin J
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Jul; 43(7):1051-1062. PubMed ID: 37488787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of microRNAs in Development of Colitis-Associated Colorectal Cancer.
    Bocchetti M; Ferraro MG; Ricciardiello F; Ottaiano A; Luce A; Cossu AM; Scrima M; Leung WY; Abate M; Stiuso P; Caraglia M; Zappavigna S; Yau TO
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33921348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-7 negatively regulates Toll-like receptor 4 signaling pathway through FAM177A.
    Chen H; Guo M; Yue D; Zhao J; Zhou Y; Chen C; Liang G; Xu L
    Immunology; 2021 Jan; 162(1):44-57. PubMed ID: 32852789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.